Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

As global tariffs continue to increase the cost of imported ingredients and products, many companies in the animal health ...

The pet dietary supplements market is estimated at USD 2.71 billion in 2025 and is projected to reach USD 4.11 billion by 2030, at a CAGR of ...

Two groups that are particularly prone to social isolation – older adults and international students – felt much less lonely ...